Health Cor Management, L.P. Biogen Inc. Transaction History

Health Cor Management, L.P.

$106 Million
Q4 2022

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $66.9 Million - $92.3 Million	-343,690 Reduced 83.09%	69,950 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $2.25 Million - $2.67 Million	11,980 Added 2.98%	413,640 $84.4 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $10 Million - $12.6 Million	-51,740 Reduced 11.41%	401,660 $84.6 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $3.01 Million - $3.86 Million	-13,430 Reduced 2.88%	453,400 $109 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $36.1 Million - $47.1 Million	127,530 Added 37.59%	466,830 $132 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $67 Million - $107 Million	258,790 Added 321.44%	339,300 $117 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $17.2 Million - $20.2 Million	70,950 Added 742.15%	80,510 $22.5 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.26 Million - $3.4 Million	9,560 New	9,560 $2.34 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $12.4 Million - $16.4 Million	-48,002 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $12.9 Million - $16.4 Million	48,002 New	48,002 $15.2 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $78.5 Million - $109 Million	-356,860 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $77.6 Million - $87 Million	356,860 New	356,860 $83.1 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $14.5 Million - $22.6 Million	-66,780 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $18.6 Million - $23.6 Million	66,780 New	66,780 $20.1 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $3.23 Million - $4.1 Million	-11,610 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $3.41 Million - $4.46 Million	11,610 New	11,610 $4.1 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.

Account